共 77 条
[1]
Dorbala S(2021)ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2—evidence base and standardized methods of imaging Circ Cardiovasc Imaging 14 1945-1955
[2]
Ando Y(2018)Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis Eur J Nucl Med Mol Imaging 45 2404-2412
[3]
Bokhari S(2016)Nonbiopsy diagnosis of cardiac transthyretin amyloidosis Circulation 133 1769-1774
[4]
Dispenzieri A(2021)Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2—evidence base and standardized methods of imaging J Nucl Cardiol 28 e006075-1084
[5]
Falk RH(2019)Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis Circ Heart Fail 12 1076-347
[6]
Ferrari VA(2005)Noninvasive etiologic diagnosis of cardiac amyloidosis using J Am Coll Cardiol 46 337-220
[7]
Treglia G(2017)Tc-3, 3-diphosphono-1, 2-propanodicarboxylic acid scintigraphy J Intern Med 281 210-1350
[8]
Glaudemans A(2015)One mutation, two distinct disease variants: unravelling the impact of transthyretin amyloid fibril composition Amyloid 22 1344-506
[9]
Bertagna F(2017)Usefulness of Eur Heart J Cardiovasc Imaging 18 503-1815
[10]
Hazenberg BPC(2021)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis J Nucl Cardiol 28 1808-889